
Get exclusive money-saving offers and guides
Straight to your inbox
Posted
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Acrux Limited is a biotechnology business based in Australia. Acrux shares (ACR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Acrux has a trailing 12-month revenue of around $1.3 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Acrux's share price has had significant positive movement.
Its last market close was $0.18, which is 0.00% up on its pre-crash value of $0.18 and 71.43% up on the lowest point reached during the March crash when the shares fell as low as $0.105.
If you had bought $1,000 worth of Acrux shares at the start of February 2020, those shares would have been worth $594.60 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $972.97.
52-week range | $0.105 - $0.25 |
---|---|
50-day moving average | $0.1797 |
200-day moving average | $0.158 |
Target price | $0.23 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.05 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.18 on 2020-10-22
1 week (2021-01-07) | 9.09% |
---|---|
1 month (2020-12-17) | -2.70% |
3 months (2020-10-16) | -5.26% |
6 months (2020-07-17) | 12.50% |
1 year (2020-01-16) | -7.69% |
---|---|
2 years (2019-01-16) | -7.69% |
3 years (2018-01-16) | 12.50% |
5 years (2016-01-15) | -73.53% |
Revenue TTM | $1.3 million |
---|---|
Gross profit TTM | $-3,759,000 |
Return on assets TTM | -35.72% |
Return on equity TTM | -54.46% |
Profit margin | 0% |
Book value | 0.076 |
Market capitalisation | $30.4 million |
TTM: trailing 12 months
We're not expecting Acrux to pay a dividend over the next 12 months.
Over the last 12 months, Acrux's shares have ranged in value from as little as $0.105 up to $0.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Acrux's is 1.2377. This would suggest that Acrux's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.